SARA COX: Open Payments
NPI 1366492217 · GREENVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 53 payments from 15 companies in 2025. Trend: 2023 $1,035 · 2024 $803 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $154 |
| E.R. Squibb & Sons, L.L.C. | 13 | $138 |
| Novo Nordisk Inc | 6 | $136 |
| Medtronic, Inc. | 1 | $75 |
| Amgen Inc. | 3 | $56 |
| Alnylam Pharmaceuticals Inc. | 3 | $52 |
| Actelion Pharmaceuticals US, Inc. | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Lilly USA, LLC | 3 | $49 |
| CARDIVA MEDICAL, INC. | 1 | $35 |
Products named: CAMZYOS, VYNDAQEL, Wegovy, ELIQUIS, AURORA EV-ICD MRI SURESCAN, Repatha, ONPATTRO, LEQVIO.
Industry payments across MI — which companies pay providers there.
